Combating Counterfeit, Falsified and Substandard Medicines: Defining the Way Forward?
(Chatham House, 23.11.10) Counterfeit, falsified and substandard medicines pose a serious threat to human health, particularly in poorer countries with weak regulatory mechanisms.